AbbVie
ABBV
ABBV
1,604 hedge funds and large institutions have $61.7B invested in AbbVie in 2015 Q3 according to their latest regulatory filings, with 77 funds opening new positions, 622 increasing their positions, 680 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
23% less capital invested
Capital invested by funds: $80.2B → $61.7B (-$18.5B)
30% less first-time investments, than exits
New positions opened: 77 | Existing positions closed: 110
38% less funds holding in top 10
Funds holding in top 10: 142 → 88 (-54)
Holders
1,604
Holding in Top 10
88
Calls
$1.2B
Puts
$907M
Top Buyers
| 1 | +$549M | |
| 2 | +$544M | |
| 3 | +$344M | |
| 4 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
+$216M |
| 5 |
Two Sigma Investments
New York
|
+$196M |
Top Sellers
| 1 | -$1.44B | |
| 2 | -$715M | |
| 3 | -$523M | |
| 4 |
PC
PointState Capital
New York
|
-$294M |
| 5 |
State Street
Boston,
Massachusetts
|
-$249M |